ABSTRACT In an effort to explore strategies to control Clostridium perfringens, we investigated the synergistic effect of a ubiquitous bacterial second messenger 3′,5′-cyclic diguanylic acid (c-di-GMP) with penicillin G in a broiler challenge model. All chicks were inocu- 
INTRODUCTION
Worldwide enteric diseases in poultry lead to enormous economic losses annually. Correspondingly, efficient control of these diseases may potentially save poultry producers millions of dollars. An enteric pathogen of particular concern in poultry is Clostridium perfringens type A, the causative agent of necrotic enteritis (NE, characterized by necrotic lesions in the small intestine). This ubiquitous pathogen is a low G+C anaerobic spore-forming bacterium naturally found in soil and sewage and in the normal bacterial flora of the gastrointestinal tract (GIT) of many animals and humans (Collier and Van Der Klis, 2003) .
Normally, many avian species have less than 10 4 cfu of nonpathogenic C. perfringens in their normal gut flora. However, increases in C. perfringens counts in the GIT due to any predisposing factors supporting their propagation would result in the development of NE (McDevitt et al., 2006) . Indeed, massive colonization (>10 4 cfu) of C. perfringens in the gut could lead to acute clinical conditions resulting in mortality rates from 10 to 40% in the affected flock (McDevitt et al., 2006) . Moreover, subclinical infections could lead to production losses associated with reduced weight gain and increased feed conversion ratio. Intestinal damages caused by NE give bacteria access to the bile duct and blood stream, consequently damaging the other organs of birds (Timbermont et al., 2011) . Due to the zoonotic character of C. perfringens type A, poultry meat contaminated with this pathogen can therefore be a source of food poisoning in humans, causing a major public
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Mussarat Fatima ,* Heidi Rempel ,* Xiaomei Tallie Kuang ,* Kevin J. Allen , † Kimberly M. Cheng , ‡ François Malouin , § and Moussa S. Diarra * 1 health concern (Brynestad and Granum, 2002; Van Immerseel et al., 2004) . Antimicrobial compounds including penicillin are used to treat NE caused by C. perfringens. Although treatments may be effective, a more proactive practice focusing on NE prevention would be the use of ionophores (salinomycin) or other antimicrobial agents such as avilamycin, virginiamycin, bacitracin, and avoparcin to effectively minimize the growth of C. perfringens (Kocher, 2003) . Moreover, the use of such agents also minimizes the rate of mortality and morbidity due to subclinical and clinical diseases and is of obvious economic benefit to producers (VanImmerseel et al., 2009 ). The use of antimicrobials can result in the development, maintenance, and potential dissemination of antimicrobial resistance genes in food-producing animals (Butaye et al., 2003; . In addition, antimicrobial residues and resistant bacteria may find their way into the environment from fecal materials and litter (Furtula et al., 2010; Merchant et al., 2012) . Increasing public health concerns due to spread of antimicrobial resistance and the concomitant reduction in therapeutic efficacy and potential for treatment failures have led to the ban of antimicrobial agent growth promoters in European countries (Graham et al., 2007) . These authors reported that because of minor economic benefit, the use of antimicrobial agent growth promoters in poultry production should be reconsidered.
Correspondingly, in an effort to improve interventions for controlling NE in poultry, we examined the effect of 3′,5′-cyclic diguanylic acid (c-di-GMP), an immunostimulatory intracellular bacterial signaling molecule, against C. perfringens in broiler chickens. It has been shown that exogenous c-di-GMP treatment significantly reduced Staphylococcus aureus infections in an in vitro model as well as in mice (Karaolis et al., 2007a) . In addition, c-di-GMP treatment before Klebsiella pneumoniae challenge significantly reduced bacterial pneumonia and stimulated innate immunity response in a mouse model (Karaolis et al., 2007b) . In a previous study, we showed a significant increase in IgA concentration in the serum of treated birds compared with control birds, confirming the role of c-di-GMP as a mucosal adjuvant (Fatima et al., 2011) . The objective of our present study is to evaluate the in vivo effects of c-di-GMP against C. perfringens type A in a broiler chicken challenge model. We hypothesized that the universal bacterial second messenger molecules c-di-GMP when administrated with penicillin G could increase C. perfringens clearance in the chicken gut.
MATERIALS AND METHODS

Chickens and Housing
A total of 108 male 1-d-old Ross 308 broiler chicks (Western Hatchery, Abbotsford, BC, Canada) were randomly placed in 18 cages (6 chicks/cage) after visual inspection for health to remove inferior chicks from the trial. Each cage was equipped with a drinker and a feeder providing feed and water ad libitum. Heat was provided through gas-fired brooders and airflow was provided by negative pressure. The temperature was initially set at 32°C and was then gradually reduced by 1.7°C each week to reach 23°C at 35 d of age. Chicks were exposed to light for 24 h on d 1, 23 h on d 2 and 3, and 18 h thereafter (Leusink et al., 2010) . The composition of the diets used in the study was similar to a previous study (Fatima et al., 2011) . Briefly, the starter, grower, and finisher diets were formulated with wheat, barley, and corn as the principal cereals and soybean and canola meals as protein concentrates to meet the NRC (1994) nutrient requirements for broiler chickens. All experimental procedures performed in this study were approved by the Animal Care Committee of the Pacific Agri-Food Research Center (Agassiz, BC, Canada) according to guidelines described by the Canadian Council on Animal Care (CCAC, 1993) .
Experimental Challenge and Treatment
Four C. perfringens type A strains (ABB004-1534, ABB008-3964, ABB009-3791, and ABB007-3648) isolated from NE outbreak cases were used in the study. These strains were initially stored in thioglycolate supplemented with 15% glycerol at −80°C until used. The challenge doses were prepared fresh on each challenge day by cultivation into freshly prereduced cooked meat broth (Oxoid, Nepean, ON, Canada) anaerobically for 18 to 24 h at 37°C. Cells were then harvested from the supernatant by centrifugation (4,500 × g at 4°C for 10 min), and the pellets were resuspended in 10 volumes of physiological saline to have approximately 8 to 9 log 10 cfu/mL (Siragusa et al., 2008) . The doses were verified by plating onto Brucella Agar supplemented with hemin and vitamin K and incubating overnight anaerobically at 37°C. All chicks were inoculated in the crop by gavage on d 14, 15, and 16 with 9 log 10 cfu of a mixture of the 4 C. perfringens strains. At 24 d of age, they were then randomly divided into 3 treatment groups: 1) control untreated, 2) gavage with 20 nmol of c-di-GMP, and 3) intramuscularly injected (IM) with 20 nmol of c-di-GMP. On the same day, all 3 groups received penicillin G (300,000 UI/L) in drinking water for 5 d (until d 28) to measure synergistic effects of c-di-GMP and penicillin against colonization by C. perfringens.
Sample Collection and Microbial Counts
On d 21, 28, and 35, 2 birds from each cage (12/ treatment) were euthanized by cervical dislocation, and the ceca and ileum were removed. Samples (pooled samples from 2 birds of the same pen constituting 1 sample) were then 10-fold diluted for bacteriological analysis. A total of 108 samples [54 intestines (ileum), 18/sampling day: 6/treatment; and 54 ceca, 18/sampling day: 6/treatment] were analyzed. Clostridium perfringens was enumerated according to Knarreborg and Simon (2002) . Briefly, samples were spread on tryptose sulfite agar (Oxoid) supplemented with cycloserine (SR088E, Oxoid) and incubated anaerobically for 24 h at 37°C. Lactobacillus spp. populations were quantified using Lactobacilli MRS Agar (Oxoid) according to the manufacturer's methods.
At d 21, 28, and 35 of age, the intestines of the birds (2 per pen) were examined for evidence of NE. The intestines were longitudinally opened and intestinal mucosa were scored on a scale of 0 to 3 for NE lesions for the upper gut, mid gut, lower gut, and ceca according to the method of Collier and Van Der Klis (2003) .
Detection of Virulence and Antibiotic Resistance Genes
The presence of alpha-toxin (cpa), beta-toxin (cpb), epsilon-toxin (etx), iota-toxin (iA), enterotoxin (cpe), and beta2-toxin (cpb2) was investigated by PCR in tested C. perfringens strains and subsequently in extracted cecal DNA from challenged birds at d 21, 28, and 35 of age using specific primers (Das et al., 2008) . The PCR amplifications were performed using AccuStart Taq PCR Supermix (Bio-Rad Laboratories Inc., Hercules, CA) and 0.5 µM concentration of each primer. The PCR reactions involved 30 cycles of denaturation (94°C for 1 min.), annealing (55°C for 1 min), and extension (72°C for 1 min). The β-lactamase bla C-MY-2 , bla SHV , and bla TEM genes were screened using primers as previously described (Merchant et al., 2012) . The PCR products were run on a 1.5% Tris-acetate-EDTA buffer agarose electrophoresis gel stained with ethidium bromide (1 µL/10 mL) and amplicon sizes were referenced to a 1-kbp gene ruler (Fermentas, Burlington, Canada).
Culture Independent Method for Analysis of the Cecal Microflora
At each sampling day (21, 28, 35), 6 ceca samples from each treatment group (c-di GMP gavage, c-di-GMP IM, and control) were pooled for the microbiota analysis. The DNA of these 9 cecal samples was thus extracted using QIAamp DNA Stool Mini Kit (Qiagen, Mississauga, ON, Canada) and stored at −80°C until used. Microbial flora variation in these samples was determined by the amplified fragment length polymorphism (AFLP). Extracted ceca DNA was first amplified using FAM labeled 16S rRNA gene primer (forward-5′CCT ACG GGA GGC AGC AG-3′; reverse-5′ CCG TCA ATT CCT TTG AGT TT-3′) by PCR and sent to the University of British Columbia Nucleic Acid Protein Service Unit (Vancouver, BC, Canada) to perform the AFLP test. The images were analyzed using Pearson's product-moment correlation coefficient to construct dendrograms (BioNumerics Analysis software version 5.10, Applied Maths, Ghent, Belgium).
Statistical Analysis
Bacterial counts were log-transformed and analyzed according to a randomized complete block design using the repeated statement of SAS (SAS Institute Inc., Cary, NC) considering cage as the experimental unit. The association test of Cochran-Mantel-Haenszel was used to determine the relationship between the frequency of screened genes and the treatment using the FREQ procedures. The least significance difference was used to separate treatment means whenever the F-value was significant. The P-value (0.05) was used to determine significance.
RESULTS AND DISCUSSION
Partial control of NE can be achieved by using growth-promoting antibiotics that alter the microbial composition of the GIT and increase availability of nutrients to the host (Butaye et al., 2003; VanImmerseel et al., 2004) . However, aside from their beneficial effects, it seems possible that antibiotics may have a negative correlation with the health and well-being of the animal (Brisbin et al., 2008) . The impact of antimicrobials used in chicken immunity is poorly understood, and the use of agents that enhance the immunological responses to infection needs to be developed for chicken production. The immune stimulatory effects of c-di-GMP against infections have previously been reported (Karaolis et al., 2007a) . Indeed, treatment with c-di-GMP in mouse infection models have shown significant reductions in K. pneumoniae, S. aureus, and Streptococcus pneumoniae counts, resulting in increased survival and protective effects (Karaolis et al., 2007a,b; Hu et al., 2009) . Furthermore, the intranasal administration of antigen with c-di-GMP significantly stimulated humoral and cellular immune responses at systemic and mucosal levels, showing, as mentioned above, the beneficial effect of c-di-GMP (Ebensen et al., 2007) .
Clostridium Challenge Model
The present study investigated the effect of c-di GMP against C. perfringens in a broiler chicken challenge model. Based on gross observations from d 0 to 35, the health of the birds treated with c-di-GMP in the trial was good, with no mortalities due to the Clostridium challenge observed. However, a single mortality was observed in a cage of control birds due to undetermined physiological conditions. Despite administration of penicillin G in drinking water, some c-di-GMP untreated (control) birds also showed some sickness symptoms such as reduced weight gain, ruffled feathers, and movement difficulties (data not shown). Intestinal mucosae examinations were initiated after challenge at 21 d of age. Despite administration of high doses of C. perfringens, the birds did not develop obvious coccidiosis (no Eimeria used in this model) or intestinal NE lesions during the study period, confirming that the C. perfringens infection model used was not a NE model as previously reported (Siragusa et al., 2008) . In birds examined on d 21, 28, and 35, small foci of necrosis of about 1 mm in diameter (lesions scoring 1 in the upper intestine) were observed in a few birds. Several factors may have been associated with our inability to induce experimental NE using this model, with the most likely being linked to the virulence characteristics of C. perfringens strains used in our challenge (Lee et al., 2011) .
The production of alpha-toxin is thought to play a major role in the virulence of C. perfringens. In the present study, the alpha-toxin gene (cpa) was detected in all 4 C. perfringens strains used for challenge, whereas the cpb2 gene was additionally detected in only one strain (ABB007-3648). None of the other screened genes (etx, iA, cpe, cpb) were detected in challenge strains. Furthermore, screening DNA extracted from cecal samples by PCR amplification revealed the presence of the cpa gene in 13.9 and 44.4% of samples on d 21 and 35, respectively. This gene was detected in 30% of the cecal samples from birds treated with IM administration of c-di-GMP at both 21 and 35 d, whereas on the same days the prevalence of cpa increased from 10 to 60% in control birds and those receiving c-di-GMP by gavage (Figure 1 ). The cpb2 gene was detected in one of the challenge C. perfringens isolates; however, only one cecal sample from c-di-GMP IM-administered birds was positive for this gene. Detection of these genes was not correlated with NE in our experimental birds, suggesting that other factors could be involved in the induction of disease. Conditions that promote excessive growth of C. perfringens in the chicken intestine and lead to toxin production causing mucosal lesions are less understood. It has been reported that the alpha-toxin may not be required for the development of NE as birds challenged with C. perfringens strains lacking this toxin were shown to develop NE (Van Immerseel et al., 2009; Lee et al., 2011; Timbermont et al., 2011) . The mechanism behind the negative effect of c-di-GMP on bacterial virulence factors seems to be complex; however, the importance of this molecule in bacterial regulation of virulence factors including motility and toxin production has been shown (Bordeleau et al., 2011; Srivastava et al., 2011) . Thus, the apparent effect of c-di-GMP administered IM on the prevalence of Clostridium alpha-toxin observed in the present study requires additional investigation.
Bacterial Enumeration
For the treatment of C. perfringens in broiler production, penicillin has been used, but few studies actually report the efficacy of this clinically important antibiotic (Gadbois et al., 2008) . Furthermore, the current global concern over the use of important antibiotics such as penicillin has already resulted in the loss of many very useful products due to the development of resistance with no new replacements on the horizon. In the present study, we hypothesized that the universal bacterial second messenger molecules c-di-GMP when administrated with penicillin G could increase C. perfringens clearance in the chicken gut. Detection of bacterial diversity in broiler chickens by 16S rRNA gene sequencing revealed that almost 70% of ileum sequences represent Lactobacillus spp., whereas the ceca population was abundant in Clostridiaceae-related sequences (Lu et al., 2003) . In the present study, at d 21 (i.e., 4 d after challenge) and before the administration of c-di-GMP, Clostridium numbers were higher in the ceca than in the ileum by about 2 log, confirming the ceca as the ecological niche for this bacterium. Administration of cdi-GMP on d 24 followed by penicillin G treatment led to significant (P < 0.05) decreases in Clostridium numbers in both the ileum and ceca as observed on d 28. On the same sampling day, ceca from birds treated with 20 nmol of c-di-GMP by gavage as well as both ceca and ileum from birds treated with 20 nmol of c-di-GMP IM showed the lowest C. perfringens number per gram of sample, but no significant treatment effects (P > 0.05) were noted. However, on d 35 of age, IM administration of 20 nmol of c-di-GMP significantly (P < 0.05) reduced the C. perfringens numbers in the ceca (Figure  2A) , suggesting a possible synergistic activity between penicillin G and c-di-GMP against C. perfringens in broiler ceca. Similarly to that used in the present study, a C. perfringens colonization model similar in 2-wk-old chickens showed that administration of lupulone, a hop plant (Humulus lupulus) bitter acid, decreased intestinal levels of inoculated pathogenic clostridia (Siragusa et al., 2008) . The decrease of C. perfringens number in the ceca could lead to the decrease in translocation of this pathogen to the upper intestine. The observed decrease of Clostridium numbers also correlated with the decrease of the cpa gene prevalence mentioned above. We used 4 strains (all from NE cases) to simulate the natural C. perfringens population in the gut. Because C. perfringens counts were positively associated with the severity of NE-specific lesions (Srivastava et al., 2011) , our findings indicate that strategies using c-di- GMP combined with penicillin G could be developed to decrease C. perfringens numbers in the broiler gut.
Lactobacillus spp. are normal inhabitants of the GIT of the chicken, and some strains of Lactobacillus spp. are used as probiotic bacteria due to their health benefits, which include possible immune stimulation (Peña et al., 2005; Haghighi et al., 2006) . Because some antimicrobial agents were shown to be associated with the reduction of Lactobacillus spp. frequency in the broiler gut (Torok et al., 2011) , we investigated the effect of our treatments on Lactobacillus numbers. Regardless of the treatments applied, Lactobacillus numbers were higher in the ceca than in the intestine (P < 0.05) at all sampling days ( Figure 2B ). Our data suggest that administration of 20 nmol of c-di-GMP does not wipe out the natural microbial flora of the chicken, which is common during antibiotic treatments. Whether this high Lactobacillus population in ceca translates to the reduced colonization by pathogenic bacteria was not investigated.
Antibiotic Resistance Genes
The application of culture-independent approaches, such as PCR and DNA-microarray to study antibiotic resistance has uncovered a vast diversity of antibiotic resistance genes in bacteria. Using DNA microarrays, we described several antibiotic resistance genes, including the extended-spectrum β-lactamases (ESBL) bla CMY-2 , bla SHV , and bla TEM . These genes confer resistance to β-lactam antibiotics such as ceftiofur, ceftriaxone, and ampicillin in gram-negative bacteria isolated from broiler gut samples (Bonnet et al., 2009) . Because penicillin G was used in this study, we developed a PCR method to detect bla CMY-2 , bla SHV , and bla TEM genes directly from gut DNA extracts. From d 21 to 35, no significant treatment effect was detected for the prevalence of the respective screened bla genes in 54 ceca samples. The bla CMY-2 gene was detected in all screened cecal samples from all treatment groups except in birds from one pen of the control group at d 35. On the same day of age, the bla TEM gene was detected in only one pen of the treatment group receiving c-di-GMP IM, whereas bla SHV was found in a pen of the control group that was also negative to bla CMY-2 . The sources of these ESBL (bla CMY-2 , bla SHV , and bla TEM ) genes, which were known to be carried by gram-negative bacteria such as Salmonella spp. and E. coli Merchant et al., 2012) , were not determined in this study. However, our study confirmed the presence of such genes in the ceca of broiler chickens independent from the used β-lactam antibiotics. The prevalence of such genes is of concern because they can inactivate extended-spectrum cephalosporins, such as ceftriaxone, that are commonly used in the treatment of invasive Salmonella infections. Furthermore, resistance genes to other antibiotics such as tetracycline and amikacin can be co-located on ESBL clarifying plasmids (Hamilton et al., 2012) . Our findings suggest that additional research is needed to determine the origins of ESBL genes in broilers and to evaluate the in vivo effect of c-di-GMP on the overall diversity of antibiotic resistance machinery in the poultry gut microbiome.
Gut Microflora
The identity of approximately 90% of bacteria in the chicken GIT is unknown (Apajalahti et al., 2004) , and previous research studies have been conducted to evaluate the potential effects of alternative feeding practices on the dynamic of some of the chicken gut microflora members (Leusink et al., 2010) . Additional work needs to be done for establishment of the nature of shifts in the chicken gut microflora in response to different feed regimens including new alternative approaches that are being used. Recent developments in molecular microbiology and computation analysis can generate infor- mation about bacterial population genetics and species evolution that has not been accessible in the past (Hamady et al., 2010) . In this study, we used AFLP to gain insight on the dynamic of the cecal microfloral shift from d 21 to 35 following a C. perfringens challenge and c-di-GMP administration (Figure 3 ). The generated dendrograms from 9 cecal samples (1 pooled sample from each treatment/sampling day) showed that at 70% similarity, cecal microflora from 35-d-old birds gavaged with c-di-GMP clustered distinctly from the cecal microflora of other group. At 80% similarity, the microflora of the 21-d-old birds treated IM with c-di-GMP also were distinct. The remaining microflora clustered together or alone at varying degrees of similarity. For example, microflora from 28-d-old birds treated with ci-di-GMP by gavage or IM were similar at 96%. Predominantly, results showed 92% similarity between ceca of 21-d-old control birds and 35-d-old birds treated IM with c-di-GMP. This indicates that c-di-GMP IM treatment might be effective in restoring or maintaining a normal host microflora following C. perfringens challenge. Limited information exists about the broiler chicken gut microflora after a C. perfringens infection. However, suppression of some Lactobacillus species had been reported after C. perfringens infection (Feng et al., 2010) . It would be interesting to identify the specific bacterial population present in our cecal samples to estimate the shift of microbial composition induced by our treatments.
In conclusion, it appears that c-di-GMP can modulate C. perfringens colonization in the host ceca without altering the normal microbiota. Additionally, c-di-GMP did not alter the commensal bacterial community of the intestine, which is known to stimulate the host immune response, and did not act as an antimicrobial drug in selecting resistant genes such as ESBL genes. It will be interesting to further study variations in the bacterial community in response to c-di-GMP, as well as the incidence, movement, spread, and persistence of bacterial strains representing major threats to humans, birds, and the environment. 
